BiotechTube
Intraop Medical

Intraop Medical

Santa Clara, United States· Est.
intraop.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $8.5M

Overview

Intraop Medical is a privately held, commercial-stage company that has been a leader in portable electron beam therapy since 1997. Its core technology, the Mobetron, is a self-shielded, mobile linear accelerator that brings radiation directly to the operating room for IORT and treats non-melanoma skin cancer in a clinic setting. The company is now at the forefront of the emerging FLASH radiotherapy field, with its approved platform being used in multi-institutional clinical trials to investigate the potential of ultra-high dose rate treatment to spare healthy tissue. With over forty units installed globally, Intraop has established a significant clinical footprint in leading cancer centers.

Oncology

Technology Platform

Mobile, self-shielded electron linear accelerator (LINAC) platform (Mobetron) capable of delivering intraoperative radiation therapy (IORT), non-invasive skin cancer treatment, and ultra-high dose rate (FLASH) radiotherapy.

Funding History

2
Total raised:$8.5M
Series A$8M
Grant$500K

Opportunities

FLASH radiotherapy represents a paradigm-shifting opportunity; if clinical trials confirm its tissue-sparing effect, it could dramatically expand the use and efficacy of radiation treatment.
The company's first-mover advantage with an installed, clinically-approved platform positions it to capture significant early market share.
The high unmet need in cancers like pancreatic ductal adenocarcinoma provides a clear pathway to demonstrate value and drive adoption of its core IORT technology.

Risk Factors

The company's future growth is heavily dependent on the successful clinical translation of the FLASH effect, which remains unproven in humans.
It faces competition from large, well-capitalized medical device companies that may enter the FLASH space.
Market adoption and securing favorable reimbursement for new procedures like FLASH and IORT in new indications are significant commercial execution risks.

Competitive Landscape

Intraop is a pioneer and niche leader in portable electron IORT, with limited direct competition in that specific mobile form factor. In the broader FLASH radiotherapy space, it faces emerging competition from both startups and large oncology capital equipment vendors (e.g., Varian, Elekta) who are developing photon, proton, or electron-based FLASH solutions. Its key competitive advantage is an already-deployed, clinically-validated platform being used in active trials.

More companies in Radiopharmaceuticals →More companies in United States →